Sintx Technologies, Inc.

NasdaqCM SINT

Sintx Technologies, Inc. Current Liabilities for the quarter ending September 30, 2024

Sintx Technologies, Inc. Current Liabilities is NA for the quarter ending September 30, 2024. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Sintx Technologies, Inc. Current Liabilities for the quarter ending September 30, 2021 was USD 3.15 M, a -6.13% change year over year.
  • Sintx Technologies, Inc. Current Liabilities for the quarter ending September 30, 2020 was USD 3.36 M.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
NasdaqCM: SINT

Sintx Technologies, Inc.

CEO Mr. Eric K. Olson
IPO Date Feb. 13, 2014
Location United States
Headquarters 1885 West 2100 South
Employees 43
Sector Technology
Industries
Description

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Similar companies

NXL

Nexalin Technology, Inc.

USD 2.92

1.39%

BJDX

Bluejay Diagnostics, Inc.

USD 3.68

-12.80%

NUWE

Nuwellis, Inc.

USD 1.23

-1.60%

BBLG

Bone Biologics Corporation

USD 1.11

-0.89%

RSLS

ReShape Lifesciences Inc.

USD 3.77

0.00%

IRIX

IRIDEX Corporation

USD 1.64

0.00%

StockViz Staff

February 3, 2025

Any question? Send us an email